Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 105-108

  Chu, Pei Yi ^a   Cheng, Chih Jen ^b   Tseng, Min Hua ^a,c   Yang, Sung Sen ^a,b   Chen, Hsiang Cheng ^b   Lin, Shih Hua ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Gene; Hyperthyroidism; Hypokalemia; Paralysis; Potassium channel

Indexed keywords

GENOMIC DNA; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ18 PROTEIN, HUMAN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PARALYSIS; PERIODIC PARALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPORADIC HYPOKALEMIC PARALYSIS; THYROTOXIC PERIODIC PARALYSIS; BLOOD; CHROMOSOME 17; GENETICS; HYPOKALEMIC PERIODIC PARALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; URINE;

ADULT; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC VARIATION; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84866489101     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.08.004     Document Type: Article

References (30)

1. Lin, S.H., Lin, Y.F., Chen, D.T., Chu, P., Hsu, C.W., Halperin, M.L., Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med 164 (2004), 1561–1566.
2. Ptacek, L.J., Tawil, R., Griggs, R.C., et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77 (1994), 863–868.
3. Venance, S.L., Cannon, S.C., Fialho, D., et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129 (2006), 8–17.
4. Jurkat-Rott, K., Mitrovic, N., Hang, C., et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97 (2000), 9549–9554.
5. Matthews, E., Labrum, R., Sweeney, M.G., et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 72 (2009), 1544–1547.
6. Ruff, R.L., Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology, 74, 2010, 269 [author reply 169–270].
7. Ko, G.T., Chow, C.C., Yeung, V.T., Chan, H.H., Li, J.K., Cockram, C.S., Thyrotoxic periodic paralysis in a Chinese population. QJM 89 (1996), 463–468.
8. Lin, S.H., Thyrotoxic periodic paralysis. Mayo Clin Proc 80 (2005), 99–105.
9. Chen, K.M., Hung, T.P., Lin, T.Y., Periodic paralysis in Taiwan. Clinical study of 28 cases. Arch Neurol 12 (1965), 165–171.
10. Phakdeekitcharoen, B., Ruangraksa, C., Radinahamed, P., Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 19 (2004), 2013–2018.
11. Sung, C.C., Cheng, C.J., Lo, Y.F., et al. Genotype and phenotype analysis of patients with sporadic periodic paralysis. Am J Med Sci 343 (2012), 281–285.
12. Lin, S.H., Hsu, Y.D., Cheng, N.L., Kao, M.C., Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in Chinese patients with hypokalemic periodic paralysis. Am J Med Sci 329 (2005), 66–70.
13. Kung, A.W., Lau, K.S., Fong, G.C., Chan, V., Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89 (2004), 1340–1345.
14. Ng, W.Y., Lui, K.F., Thai, A.C., Cheah, J.S., Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid 14 (2004), 187–190.
15. Ryan, D.P., da Silva, M.R., Soong, T.W., et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140 (2010), 88–98.
16. Cheng, C.J., Lin, S.H., Lo, Y.F., et al. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem 286 (2011), 27425–27435.
17. Lin, S.H., Huang, C.L., Mechanism of thyrotoxic periodic paralysis. J Am Soc Nephrol 23 (2012), 985–988.
18. Jongjaroenprasert, W., Phusantisampan, T., Mahasirimongkol, S., et al. A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis. J Hum Genet 57 (2012), 301–304.
19. Lin, S.H., Chu, P., Cheng, C.J., Chu, S.J., Hung, Y.J., Lin, Y.F., Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Crit Care Med 34 (2006), 2984–2989.
20. Shiang, J.C., Cheng, C.J., Tsai, M.K., et al. Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years. Eur J Endocrinol 161 (2009), 911–916.
21. Plaster, N.M., Tawil, R., Tristani-Firouzi, M., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001), 511–519.
22. Chan, A., Shinde, R., Chow, C.C., Cockram, C.S., Swaminathan, R., In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303 (1991), 1096–1099.
23. Lee, K.O., Taylor, E.A., Oh, V.M., Cheah, J.S., Aw, S.E., Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 337 (1991), 1063–1064.
24. Maciel, R.M., Lindsey, S.C., Dias da Silva, M.R., Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nature reviews. Endocrinology 7 (2011), 657–667.
25. Clausen, T., Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 24 (2010), 595–605.
26. Puwanant, A., Ruff, R.L., INa and IKir are reduced in type 1 hypokalemic and thyrotoxic periodic paralysis. Muscle Nerve 42 (2010), 315–327.
27. + current. Neurology 53 (1999), 1556–1563.
28. + overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci U S A 106 (2009), 4036–4041.
29. Davies, N.P., Eunson, L.H., Samuel, M., Hanna, M.G., Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. Neurology 57 (2001), 1323–1325.
30. Kim, J.B., Kim, M.H., Lee, S.J., Kim, D.J., Lee, B.C., The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. J Korean Med Sci 22 (2007), 946–951.